Avantor, Inc. (NYSE:AVTR) Shares Acquired by Olstein Capital Management L.P.

Olstein Capital Management L.P. boosted its position in Avantor, Inc. (NYSE:AVTRFree Report) by 51.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 356,000 shares of the company’s stock after buying an additional 121,000 shares during the period. Olstein Capital Management L.P. owned approximately 0.05% of Avantor worth $7,501,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Public Employees Retirement System of Ohio boosted its holdings in shares of Avantor by 34.1% in the third quarter. Public Employees Retirement System of Ohio now owns 346,822 shares of the company’s stock valued at $8,972,000 after acquiring an additional 88,205 shares in the last quarter. Perpetual Ltd boosted its holdings in Avantor by 38.7% during the fourth quarter. Perpetual Ltd now owns 1,766,882 shares of the company’s stock worth $37,228,000 after buying an additional 493,408 shares in the last quarter. New York State Teachers Retirement System acquired a new position in Avantor during the third quarter worth about $8,473,000. Everence Capital Management Inc. purchased a new position in Avantor in the fourth quarter valued at about $555,000. Finally, Teachers Retirement System of The State of Kentucky lifted its position in shares of Avantor by 45.8% during the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 723,178 shares of the company’s stock valued at $18,708,000 after acquiring an additional 227,200 shares during the period. 95.08% of the stock is owned by institutional investors and hedge funds.

Avantor Stock Performance

NYSE AVTR opened at $22.07 on Friday. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. The company has a market capitalization of $15.02 billion, a PE ratio of 47.97, a price-to-earnings-growth ratio of 3.53 and a beta of 1.28. The business’s 50-day moving average price is $21.50 and its 200 day moving average price is $23.39. Avantor, Inc. has a twelve month low of $19.59 and a twelve month high of $28.00.

Wall Street Analyst Weigh In

A number of analysts have commented on AVTR shares. Raymond James decreased their target price on Avantor from $29.00 to $26.00 and set an “outperform” rating on the stock in a research report on Tuesday, January 21st. Robert W. Baird decreased their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research report on Monday, October 28th. UBS Group reissued a “neutral” rating and issued a $25.00 price objective (down from $29.00) on shares of Avantor in a research note on Friday, January 17th. Wells Fargo & Company cut their target price on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Finally, Barclays lowered their price target on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday, October 25th. Three investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat.com, Avantor has a consensus rating of “Moderate Buy” and an average target price of $27.38.

Check Out Our Latest Analysis on Avantor

About Avantor

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Read More

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.